ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVCT Avacta

47.50
0.00 (0.00%)
19 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 47.50 47.00 48.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 23.25M -24.95M -0.0695 -6.83 170.54M
Avacta is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 47.50p. Over the last year, Avacta shares have traded in a share price range of 39.75p to 121.00p.

Avacta currently has 359,042,104 shares in issue. The market capitalisation of Avacta is £170.54 million. Avacta has a price to earnings ratio (PE ratio) of -6.83.

Avacta Share Discussion Threads

Showing 79826 to 79846 of 81050 messages
Chat Pages: Latest  3194  3193  3192  3191  3190  3189  3188  3187  3186  3185  3184  3183  Older
DateSubjectAuthorDiscuss
15/5/2024
11:48
Dont worry Whitey, the sane one is still here. The silence is deafening. What has Agent Smith done? Economical with the truth? Likely I would suggest. Waiting for that killer rns now.
amanitaangelicus
15/5/2024
11:44
I suspect there has already been a technical pause on the clinical trials and its been in place for some considerable time. This is why the CEO was probably asked to leave.

However no announcement can be made until something else is in place to absorb the shock. This is why Dr Coughlin has stepped up to the plate. She is going to inject a real clinical trial into the therapeutic unit.

pwhite73
15/5/2024
08:54
I wonder if there will be a 'temporary pause' on the clinical trials when some new information comes to light?
1347
15/5/2024
08:14
Raj has gone, tickboo has gone, Smith has gone, even I have gone. Everybody has gone except YOU.
pwhite73
10/5/2024
14:17
In range ... as Ticketyboo would tell us all.
amanitaangelicus
10/5/2024
09:14
Yes, the share price is far to low !!
fieldhouse
10/5/2024
06:47
TimeLord Smith gone. No comments. Something is very, very wrong. What arent they telling you?
amanitaangelicus
09/5/2024
09:14
ZERO support on the share price chart

Unchartered waters

dan_the_epic
08/5/2024
10:05
I'm in totally oversold!//
bobaxe1
08/5/2024
07:41
rato - I believe I am still correct with CSFS irrespective of the share price rise. A similar rise was once experienced by AVCT.

I see the company as another FTX where the director Sam Bankman-Fried has just been jailed for 25 years.

Other than its own RNS statements I can find no independent evidence that CSFS is trading as it claims. In their year end results published today they claim they have 906 clients. Name one.

pwhite73
07/5/2024
12:43
PWhite Avacta is a very long way away from having fda approved drugs that's the problem. It cna take years and huge sums of money to get these through and that's if they don't fail along the way which many do.
Mkt cap v what they might have rand the risks looks still to high to me ill watch and wait for now. Look at what happened to dest

bones698
07/5/2024
11:05
As Tick used to way in those halcyon days, ' range bound.
amanitaangelicus
03/5/2024
15:35
Whitey and Tratante ...Batman n Robin.I see the Non- Magnificent 7 are on cracking form. Ps Whitey , why are u STILL here? Another fake leaving post the other day. Have a lovely weekend ...
amanitaangelicus
03/5/2024
15:02
Blue finish
countbasie1
03/5/2024
09:50
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION
blackhorse23
03/5/2024
09:49
Yes mate , money moved to APH
blackhorse23
03/5/2024
08:47
Strong sell.
blueball
02/5/2024
16:41
> Trat ...please dont get too excited by your 7 upticksAman, I'm not at all excited by upticks, indeed I hadn't noticed them. > Enjoy the adulation. I'm certainly not looking for adulation, just giving my alternative opinion in response to your comment - isn't that what the board is for?> Oh yes, you wont be here long like many of the fake lth.s I'm not a fake LTH, I've been in Avacta for long time, since before the LFT was a glimmer in AS's eye. I seldom post as, to be honest, there isn't much useful discussion, mostly people parading egos and slagging each other off. Quod erat demonstrandum!
tratante
01/5/2024
16:07
Doubt it, they would have said so with some words like AS realises the TX division now requires the leadership of a cancer expert and clinician.
tratante
01/5/2024
15:40
Not sure they'd get much for him.!
filthypoor
01/5/2024
15:20
Is the plan that AS goes with the DX division ?
fieldhouse
Chat Pages: Latest  3194  3193  3192  3191  3190  3189  3188  3187  3186  3185  3184  3183  Older

Your Recent History

Delayed Upgrade Clock